Cargando…
P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430052/ http://dx.doi.org/10.1097/01.HS9.0000847736.14020.3e |
| _version_ | 1784779640196300800 |
|---|---|
| author | Chen, X. Ping, Y. Li, L. Zhang, L. Zhang, X. Huang, J. Sersch, M. Wang, Z. Song, D. Wang, H. Shen, L. Zhao, W. Zhang, H. Zhang, M. Zhang, Y. |
| author_facet | Chen, X. Ping, Y. Li, L. Zhang, L. Zhang, X. Huang, J. Sersch, M. Wang, Z. Song, D. Wang, H. Shen, L. Zhao, W. Zhang, H. Zhang, M. Zhang, Y. |
| author_sort | Chen, X. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430052 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300522022-08-31 P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA Chen, X. Ping, Y. Li, L. Zhang, L. Zhang, X. Huang, J. Sersch, M. Wang, Z. Song, D. Wang, H. Shen, L. Zhao, W. Zhang, H. Zhang, M. Zhang, Y. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430052/ http://dx.doi.org/10.1097/01.HS9.0000847736.14020.3e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Chen, X. Ping, Y. Li, L. Zhang, L. Zhang, X. Huang, J. Sersch, M. Wang, Z. Song, D. Wang, H. Shen, L. Zhao, W. Zhang, H. Zhang, M. Zhang, Y. P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title | P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_full | P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_fullStr | P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_full_unstemmed | P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_short | P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA |
| title_sort | p1218: first-in-human study of cd19/bcma dual-targeting fast car-t gc012f for patients with relapsed/refractory b-cell non-hodgkin’s lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430052/ http://dx.doi.org/10.1097/01.HS9.0000847736.14020.3e |
| work_keys_str_mv | AT chenx p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT pingy p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT lil p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangl p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangx p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT huangj p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT serschm p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT wangz p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT songd p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT wangh p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT shenl p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhaow p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangh p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangm p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma AT zhangy p1218firstinhumanstudyofcd19bcmadualtargetingfastcartgc012fforpatientswithrelapsedrefractorybcellnonhodgkinslymphoma |